Search details
1.
Non-pegylated liposomal doxorubicin (NPLD, Myocet®)â¯+â¯carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.
Gynecol Oncol
; 152(1): 68-75, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30446275
2.
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Lancet Healthy Longev
; 5(6): e392-e405, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38759667
3.
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Lancet Healthy Longev
; 5(3): e182-e193, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38432247
4.
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Lancet Oncol
; 12(6): 527-39, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21570352
5.
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.
Cancer Rep (Hoboken)
; 5(2): e1467, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34156166
6.
Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.
BMC Cancer
; 10: 375, 2010 Jul 17.
Article
in English
| MEDLINE | ID: mdl-20637124
7.
Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy.
J Neurooncol
; 95(3): 421-426, 2009 Dec.
Article
in English
| MEDLINE | ID: mdl-19557501
8.
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.
Breast
; 17(2): 180-5, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-17976988
9.
CXCR4 membrane expression in node-negative breast cancer.
Breast J
; 14(3): 268-74, 2008.
Article
in English
| MEDLINE | ID: mdl-18373506
10.
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Lancet Oncol
; 8(12): 1071-1078, 2007 Dec.
Article
in English
| MEDLINE | ID: mdl-18024211
11.
Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Lancet Oncol
; 12(2): 116, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21277543
12.
Clinical efficacy of irradiation in CLL patients: predictive value of in vitro radio-induced apoptosis.
Leuk Lymphoma
; 43(4): 827-9, 2002 Apr.
Article
in English
| MEDLINE | ID: mdl-12153172
13.
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
Thromb Res
; 106(2): 127-30, 2002 Apr 15.
Article
in English
| MEDLINE | ID: mdl-12182911
14.
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
J Clin Oncol
; 31(7): 853-9, 2013 Mar 01.
Article
in English
| MEDLINE | ID: mdl-23341517
15.
Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer.
N Engl J Med
; 349(14): 1385-7; author reply 1385-7, 2003 Oct 02.
Article
in English
| MEDLINE | ID: mdl-14523150
16.
Elevated HER2 extracellular domain level in primary breast cancer with HER2 overexpression predicts early failure of adjuvant trastuzumab.
Anticancer Res
; 32(4): 1429-33, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22493381
17.
Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
Cancer Lett
; 317(2): 207-17, 2012 Apr 28.
Article
in English
| MEDLINE | ID: mdl-22120672
18.
Clinical Improvement and Prolonged Survival With High Dose Intrathecal Methotrexate for Carcinomatous Meningitis Secondary to a Lung Adenocarcinoma.
World J Oncol
; 2(5): 262-264, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-29147258
19.
Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma.
Oral Oncol
; 47(11): 1062-8, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21840752
20.
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial.
Crit Rev Oncol Hematol
; 80(1): 160-70, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21035352